Annual Revenue
$1.92 M
-$16.13 M-89.34%
December 31, 2023
Summary
- As of February 8, 2025, AVTX annual revenue is $1.92 million, with the most recent change of -$16.13 million (-89.34%) on December 31, 2023.
- During the last 3 years, AVTX annual revenue has fallen by -$4.78 million (-71.28%).
- AVTX annual revenue is now -93.08% below its all-time high of $27.81 million, reached on December 31, 2017.
Performance
AVTX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$249.00 K
NaN%
September 30, 2024
Summary
- As of February 8, 2025, AVTX quarterly revenue is $249.00 thousand
- AVTX quarterly revenue is now -99.01% below its all-time high of $25.04 million, reached on September 30, 2017.
Performance
AVTX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$820.00 K
NaN%
September 30, 2024
Summary
- As of February 8, 2025, AVTX TTM revenue is $820.00 thousand
- AVTX TTM revenue is now -97.76% below its all-time high of $36.54 million, reached on June 30, 2018.
Performance
AVTX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
AVTX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -89.3% | - | - |
| 3 y3 years | -71.3% | -72.2% | -95.5% |
| 5 y5 years | -72.6% | -88.7% | -95.5% |
AVTX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -89.3% | at low | -98.3% | +13.7% | -95.5% | at low |
| 5 y | 5-year | -89.3% | at low | -98.3% | +13.7% | -95.5% | at low |
| alltime | all time | -93.1% | +66.9% | -99.0% | +103.9% | -97.8% | +666.3% |
Avalo Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $249.00 K(-56.4%) | $820.00 K(-57.4%) |
| Dec 2023 | $1.92 M(-89.3%) | $571.00 K(+141.9%) | $1.93 M(-14.4%) |
| Sep 2023 | - | $236.00 K(-63.3%) | $2.25 M(-86.7%) |
| Jun 2023 | - | $643.00 K(+35.4%) | $16.96 M(-2.2%) |
| Mar 2023 | - | $475.00 K(-47.0%) | $17.35 M(-3.9%) |
| Dec 2022 | $18.05 M(+234.4%) | $896.00 K(-94.0%) | $18.05 M(+3.9%) |
| Sep 2022 | - | $14.95 M(+1347.1%) | $17.37 M(+360.2%) |
| Jun 2022 | - | $1.03 M(-11.9%) | $3.77 M(-38.1%) |
| Mar 2022 | - | $1.17 M(+435.6%) | $6.10 M(+13.0%) |
| Dec 2021 | $5.40 M(-19.4%) | $219.00 K(-83.8%) | $5.40 M(-19.1%) |
| Sep 2021 | - | $1.35 M(-59.8%) | $6.67 M(+3.7%) |
| Jun 2021 | - | $3.35 M(+609.3%) | $6.44 M(+45.6%) |
| Mar 2021 | - | $473.00 K(-68.4%) | $4.42 M(-34.0%) |
| Dec 2020 | $6.70 M | $1.50 M(+34.7%) | $6.70 M(+15.8%) |
| Sep 2020 | - | $1.11 M(-17.0%) | $5.78 M(-15.9%) |
| Jun 2020 | - | $1.34 M(-51.4%) | $6.87 M(-0.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $2.75 M(+374.2%) | $6.93 M(+2.6%) |
| Dec 2019 | $6.75 M(-4.0%) | $580.80 K(-73.6%) | $6.75 M(-4761.8%) |
| Sep 2019 | - | $2.20 M(+58.1%) | -$144.80 K(-108.4%) |
| Jun 2019 | - | $1.39 M(-46.0%) | $1.73 M(-66.2%) |
| Mar 2019 | - | $2.58 M(-140.8%) | $5.12 M(-27.1%) |
| Dec 2018 | $7.03 M(-74.7%) | -$6.31 M(-255.0%) | $7.03 M(-54.9%) |
| Sep 2018 | - | $4.07 M(-14.8%) | $15.58 M(-57.4%) |
| Jun 2018 | - | $4.79 M(+6.7%) | $36.54 M(+14.5%) |
| Mar 2018 | - | $4.48 M(+100.7%) | $31.91 M(+14.7%) |
| Dec 2017 | $27.81 M(+2312.2%) | $2.23 M(-91.1%) | $27.81 M(+8.0%) |
| Sep 2017 | - | $25.04 M(>+9900.0%) | $25.76 M(+2366.3%) |
| Jun 2017 | - | $157.80 K(-58.9%) | $1.04 M(-32.1%) |
| Mar 2017 | - | $384.20 K(+112.3%) | $1.54 M(+33.3%) |
| Dec 2016 | $1.15 M | $181.00 K(-43.7%) | $1.15 M(+18.6%) |
| Sep 2016 | - | $321.50 K(-50.6%) | $972.00 K(+49.4%) |
| Jun 2016 | - | $650.50 K | $650.50 K |
FAQ
- What is Avalo Therapeutics annual revenue?
- What is the all time high annual revenue for Avalo Therapeutics?
- What is Avalo Therapeutics annual revenue year-on-year change?
- What is Avalo Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Avalo Therapeutics?
- What is Avalo Therapeutics TTM revenue?
- What is the all time high TTM revenue for Avalo Therapeutics?
What is Avalo Therapeutics annual revenue?
The current annual revenue of AVTX is $1.92 M
What is the all time high annual revenue for Avalo Therapeutics?
Avalo Therapeutics all-time high annual revenue is $27.81 M
What is Avalo Therapeutics annual revenue year-on-year change?
Over the past year, AVTX annual revenue has changed by -$16.13 M (-89.34%)
What is Avalo Therapeutics quarterly revenue?
The current quarterly revenue of AVTX is $249.00 K
What is the all time high quarterly revenue for Avalo Therapeutics?
Avalo Therapeutics all-time high quarterly revenue is $25.04 M
What is Avalo Therapeutics TTM revenue?
The current TTM revenue of AVTX is $820.00 K
What is the all time high TTM revenue for Avalo Therapeutics?
Avalo Therapeutics all-time high TTM revenue is $36.54 M